Searched for
GLENMARK PHARMACEUTICALS STOCKS
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST- Capitalmind Flexi Cap Fund exits RIL and 2 others, hikes stake in Titan Company, MCX and 16 other stocks in AprilCapitalmind Flexi Cap Fund exited Reliance Industries, Bank of Baroda, and L&T Finance in April. The fund also increased stakes in Titan Co...15 May, 2026, 11.43 AM IST
- Nifty finds support: Nagaraj Shetti spots 2 breakout stocks worth watchingNifty's Monday pullback is a technical dip, not a trend reversal, says HDFC Securities analyst Nagaraj Shetti. After forming a higher botto...14 Apr, 2026, 01.07 PM IST
- Glenmark surges 20% after major drug licensing deal with AbbVieGlenmark Pharmaceuticals shares surged following a significant licensing agreement. Ichnos Glenmark Innovation partnered with AbbVie for a ...12 Jul, 2025, 07.53 AM IST
- I-Sec maintains Reduce call on Glenmark Pharma, raises target price to Rs 1,300ICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals, revising the target price to Rs 1,300. The brokerage anticipates reve...29 May, 2025, 09.31 AM IST
- Reduce Glenmark Pharmaceuticals, target price Rs 1,265: ICICI SecuritiesICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals with a target price of Rs 1,265. The current market price is Rs 1365.9...20 Feb, 2025, 09.51 AM IST
- Buy Glenmark Pharmaceuticals, target price Rs 1,779: Choice Equity BrokingChoice Equity Broking has issued a buy call for Glenmark Pharmaceuticals, setting a target price of Rs 1,779. The brokerage projects robust...21 Nov, 2024, 09.11 AM IST
- Reduce Glenmark Pharmaceuticals, target price Rs 660: ICICI SecuritiesGlenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the y...16 Nov, 2023, 10.46 AM IST
- Buy Glenmark Pharmaceuticals, target price Rs 619.8: ICICI DirectGlenmark Pharmaceuticals, incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 17229.19 Crore) operating in Pharm...02 Jun, 2023, 12.01 PM IST
- Motilal Oswal Financial Services neutral on Glenmark Pharmaceuticals; target price: Rs 580Glenmark Pharmaceuticals, incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 17198.15 Crore) operating in Pharm...23 May, 2023, 12.18 PM IST
- Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India“This FDC has been launched under the brand name Zita®-PioMet,” the company said in a BSE filing. “This offers patients with Type 2 diabete...21 Dec, 2022, 01.40 PM IST
- Buy Glenmark Pharmaceuticals, target price Rs 580: Nomura, IndiaGlenmark Pharmaceuticals, incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 12152.98 Crore) operating in Pharm...30 Nov, 2022, 03.54 PM IST
- Stock Radar: This pharma company sees breakout after 6-month consolidation; time to buy?Short-term traders can look to buy the stock now or on dips for a possible target of Rs 474 in the next 4-6 weeks, suggested experts16 Nov, 2022, 06.53 AM IST
- Buy Glenmark Pharmaceuticals, target price Rs 440: ICICI DirectGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11089.21 Crore) operating in ...13 Sep, 2022, 11.00 AM IST
- Hold Glenmark Pharmaceuticals, target price Rs 440: ICICI DirectGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11075.10 Crore) operating in ...17 Aug, 2022, 11.47 AM IST
- Glenmark Pharmaceuticals gains 7% on Q2 results; brokerages maintain buyThe company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011, Glenmark Pharmaceuticals said in a statemen...31 Oct, 2012, 11.27 AM IST
- Glenmark surges 12% on BSE on Sanofi-Aventis licensing pactShares of pharma firm Glenmark Pharmaceuticals today vaulted by 12 per cent on the Bombay Stock Exchange to touch a year-high of Rs 303.80 ...03 May, 2010, 11.33 AM IST
Load More
